HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Jonathan M Brotchie Selected Research

Jonathan M Brotchie Research Topics

Disease

69Parkinson Disease (Parkinson's Disease)
10/2015 - 05/2002
58Dyskinesias (Dyskinesia)
10/2015 - 02/2003
13Parkinsonian Disorders (Parkinsonism)
10/2015 - 05/2002
5Dystonia (Limb Dystonia)
06/2011 - 01/2002
4Chorea (Rheumatic Chorea)
06/2011 - 02/2004
3Disease Progression
01/2010 - 07/2004
2Impulse Control Disorders (Kleptomania)
02/2015 - 02/2011
2Hyperkinesis
11/2006 - 02/2003
1Bipolar Disorder (Mania)
10/2015
1Neuroblastoma
10/2015
1Diabetes Mellitus
03/2015
1Secondary Parkinson Disease (Secondary Parkinsonism)
11/2014
1Hallucinations (Hallucination)
05/2012
1Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2011
1Catalepsy
09/2008
1Atrophy
07/2008
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2008

Drug/Important Bio-Agent (IBA)

58Levodopa (L Dopa)FDA LinkGeneric
10/2015 - 02/2003
311- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
10/2015 - 08/2003
21Dopamine (Intropin)FDA LinkGeneric
01/2015 - 05/2002
45-HT1A Serotonin ReceptorIBA
10/2015 - 10/2011
4Dopamine Agonists (Dopamine Agonist)IBA
02/2015 - 01/2004
4Amantadine (Aman)FDA LinkGeneric
10/2013 - 07/2004
4Dihydroxyphenylalanine (Dopa)IBA
06/2013 - 02/2004
4etiracetam (levetiracetam)FDA LinkGeneric
07/2004 - 11/2003
3Serotonin (5 Hydroxytryptamine)IBA
10/2015 - 07/2009
3Dopamine Agents (Dopaminergic Agents)IBA
10/2013 - 09/2008
3Messenger RNA (mRNA)IBA
01/2012 - 10/2003
3Reserpine (Serpasil)FDA Link
09/2010 - 02/2003
23- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridineIBA
02/2015 - 08/2012
2Neurotransmitter Agents (Neurotransmitter)IBA
02/2013 - 01/2013
2N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
05/2012 - 05/2011
2WAY 100635IBA
05/2012 - 01/2012
2Adrenergic Receptors (Adrenergic Receptor)IBA
01/2012 - 08/2003
25-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2012 - 10/2011
2alpha-SynucleinIBA
01/2011 - 01/2010
2Histamine (Histamine Dihydrochloride)FDA Link
07/2010 - 07/2007
2Carbon MonoxideIBA
09/2008 - 07/2005
2Neuroprotective AgentsIBA
01/2006 - 07/2004
2Endocannabinoids (Endocannabinoid)IBA
07/2005 - 07/2005
2preproenkephalinIBA
01/2004 - 10/2003
2Opioid Peptides (Opioid Peptide)IBA
01/2004 - 10/2003
2ropinirole (Requip)FDA LinkGeneric
01/2004 - 11/2003
2CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2003 - 02/2003
1RotenoneIBA
10/2015
1Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2015
13- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA
10/2015
1pioglitazone (Actos)FDA Link
03/2015
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
03/2015
1PPAR gammaIBA
03/2015
1Dopamine D4 Receptors (Dopamine D4 Receptor)IBA
02/2015
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2015
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2015
1Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
01/2015
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
10/2013
1Dopamine AntagonistsIBA
06/2013
1entacapone (Comtan)FDA Link
03/2013
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
03/2013
1Histone Deacetylase InhibitorsIBA
02/2013
1naftazoneIBA
08/2012
1Clozapine (Clozaril)FDA LinkGeneric
05/2012
1quetiapine (Seroquel)FDA Link
05/2012
11- (2- methoxyphenyl)- 4- (4- (2- phthalimido)butyl)piperazineIBA
05/2012
1Antipsychotic Agents (Antipsychotics)IBA
05/2012
1Street Drugs (Illicit Drugs)IBA
05/2012
1KetanserinIBA
01/2012
1Serotonin ReceptorsIBA
10/2011
1mu Opioid Receptors (mu Opioid Receptor)IBA
06/2011
1Dihydrotachysterol (AT 10)IBA
06/2011
1Naltrexone (ReVia)FDA LinkGeneric
06/2011
1fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
02/2011
1cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
02/2011
1PrionsIBA
01/2011
1Famotidine (Pepcid)FDA LinkGeneric
07/2010
1metabotropic glutamate receptor 5IBA
06/2010
1pyridineIBA
06/2010
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
02/2010
1Glutamate Receptors (Glutamate Receptor)IBA
02/2010
1Dopamine D3 ReceptorsIBA
08/2009
1nociceptinIBA
10/2008
1J 113397IBA
10/2008
11-aminocyclopentane-1,3,4-tricarboxylic acidIBA
09/2008
1AdenosineFDA LinkGeneric
09/2008
1Haloperidol (Haldol)FDA LinkGeneric
09/2008
1Adenosine A2 Receptor AntagonistsIBA
09/2008
1Glutamic Acid (Glutamate)FDA Link
09/2008
1Histones (Histone)IBA
07/2008
1Nerve Growth Factors (Neurotrophins)IBA
07/2008
1sarsasapogeninIBA
07/2008
1Oxidopamine (6 Hydroxydopamine)IBA
04/2008
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
04/2008
1Receptor Activity-Modifying Protein 1IBA
04/2008
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
07/2007
1S 32504IBA
12/2006
1methoxyphenyl piperazinylIBA
11/2006
1Dopamine Receptors (Dopamine Receptor)IBA
11/2006
1imetitIBA
06/2006
1Histamine AgonistsIBA
06/2006

Therapy/Procedure

4Therapeutics
01/2010 - 04/2003
2Deep Brain Stimulation
01/2013 - 01/2013